PALATIN TECHNOLOGIES, INC.

(PTN)
  Report
Delayed Nyse  -  05/18 04:00:00 pm EDT
0.3615 USD   -7.31%
08:34aPalatin technologies reports third quarter fiscal year 2022 financial results and provides corporate update
AQ
05/17TRANSCRIPT : Palatin Technologies, Inc., Q3 2022 Earnings Call, May 17, 2022
CI
05/17PALATIN TECHNOLOGIES INC : Results of Operations and Financial Condition (form 8-K)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Palatin Technologies Starts Late-Stage Dry Eye Disease Trial

12/28/2021 | 07:53am EDT


ę MT Newswires 2021
All news about PALATIN TECHNOLOGIES, INC.
08:34aPalatin technologies reports third quarter fiscal year 2022 financial results and provi..
AQ
05/17TRANSCRIPT : Palatin Technologies, Inc., Q3 2022 Earnings Call, May 17, 2022
CI
05/17PALATIN TECHNOLOGIES INC : Results of Operations and Financial Condition (form 8-K)
AQ
05/17Earnings Flash (PTN) PALATIN TECHNOLOGIES Posts Q3 Revenue $216,097
MT
05/16PALATIN TECHNOLOGIES INC Management's Discussion and Analysis of Financial Condition a..
AQ
05/16Palatin Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Mont..
CI
05/12Palatin Technologies, Inc. announced that it expects to receive $15.03 million in fundi..
CI
04/22Palatin to present at eyecelerator @ american society of cataract and refractive surger..
AQ
03/07TRANSCRIPT : Palatin Technologies, Inc. - Special Call
CI
03/04Palatin hosting key opinion leader webinar on dry eye disease
AQ
More news
Analyst Recommendations on PALATIN TECHNOLOGIES, INC.
More recommendations
Financials (USD)
Sales 2022 0,92 M - -
Net income 2022 -31,9 M - -
Net Debt 2022 - - -
P/E ratio 2022 -2,71x
Yield 2022 -
Capitalization 83,8 M 83,8 M -
Capi. / Sales 2022 91,1x
Capi. / Sales 2023 13,2x
Nbr of Employees 26
Free-Float 95,6%
Chart PALATIN TECHNOLOGIES, INC.
Duration : Period :
Palatin Technologies, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PALATIN TECHNOLOGIES, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 0,36 $
Average target price 3,33 $
Spread / Average Target 822%
EPS Revisions
Managers and Directors
Carl Spana Director
Stephen T. Wills COO, CFO, Secretary, Treasurer & Executive VP
John K. A. Prendergast Director
Michael B. Raizman Chief Medical Officer
John Dodd Senior Vice President-Preclinical Development
Sector and Competitors
1st jan.Capi. (M$)
PALATIN TECHNOLOGIES, INC.-23.77%90
GILEAD SCIENCES, INC.-12.93%79 248
REGENERON PHARMACEUTICALS, INC.4.38%71 927
VERTEX PHARMACEUTICALS14.91%66 967
WUXI APPTEC CO., LTD.-18.77%42 682
BIONTECH SE-38.01%38 834